Dupixent Lawsuit in Maine - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Maine's 6-year statute of limitations for personal injury — the longest in the nation — provides Dupixent CTCL patients with extraordinary filing flexibility. While most states impose 2- to 3-year deadlines, Maine patients have up to 6 years from discovery of their injury to file suit. An estimated 11,000 Maine residents have been prescribed Dupixent since 2017, primarily through MaineHealth, Northern Light Health, and specialty practices in the Portland and Bangor areas. Maine lacks an NCI-designated comprehensive cancer center, but the MaineHealth Cancer Care Network and partnerships with Dana-Farber Cancer Institute in Boston provide CTCL diagnostic pathways. The District of Maine has limited pharmaceutical litigation experience, and most complex cases involve coordination with Boston-area counsel. Maine's small, aging population means a limited total claimant pool, but the state's generous SOL ensures that no Maine patient's claim will expire due to tight filing deadlines.

Written By

People's Justice Legal Research Team

Statute of Limitations

Maine: 6 years for product liability (14 M.R.S.A. § 752). Discovery rule applies — Maine's generous 6-year statute of limitations begins when the plaintiff knew or should have known of the injury and its cause.

6 years from discovery of injury

Filing Venue

Where to File in Maine

Maine has a single federal judicial district — the District of Maine, headquartered in Portland and Bangor. Maine follows a modified comparative fault system and does not cap compensatory damages in product liability cases. Maine's 6-year SOL is the longest in the nation for personal injury, providing substantial filing time for CTCL patients.

Maine Data

Exposure in Maine

Source: IQVIA prescription data estimates

Source: 14 M.R.S.A. § 752

Source: MaineHealth / Dana-Farber

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview